I-JYMed iphumeze inkqubo yokulawula umgangatho owomeleleyo, ifumana izatifikethi ezintathu ngokuqhubekayo ukuhambisa iimveliso kunye neenkonzo ezihlangabezana nemigangatho yehlabathi.Ukufezekiswa kwesatifikethi se-ISO 9001 kubonisa ukuba inkampani ineenkqubo ezichazwe kakuhle kunye nemigangatho yolawulo lwangaphakathi, eyenza ulawulo olusebenzayo lomngcipheko, ukunciphisa iimpazamo kunye nenkcitho, kunye nokuphucula ukusebenza kakuhle.
Ngelixa ilandela izibonelelo zoqoqosho, inkampani ithe gqolo ukuthobela imithetho nemigaqo yokhuseleko lokusingqongileyo. Ukufikelelwa kwesiqinisekiso se-ISO 14001 kubonakalisa ukuzibophelela kwe-JYMed Peptide kuphuhliso oluzinzileyo, ukuphunyezwa kwezenzo zokusingqongileyo, kunye nokuzalisekisa uxanduva lwayo lwentlalo njengeshishini lobuchwepheshe obuphezulu kwishishini le-biopharmaceutical.
Impilo kunye nokhuseleko lwabasebenzi zihlala ziphambili kwi-JYMed Peptide. Ukususela kuvavanyo lomngcipheko ukuya kuphuculo lweziko, ukusuka kuqeqesho lwabasebenzi ukuya kwiinkqubo zokuphendula ngokukhawuleza, inkampani iqinisekisa ukuba wonke umqeshwa unokusebenza kwindawo ekhuselekileyo nenempilo. Ukufunyanwa kwakutshanje kwesatifikethi se-ISO 45001 kubonisa intlonipho ye-JYMed Peptide ngexabiso lobomi kwaye ibonisa ukuba inkampani ifikelele kwinqanaba eliphezulu lehlabathi kulawulo lwempilo nokhuseleko emsebenzini.
Malunga JYMed
I-JYMed yinkampani yobugcisa obuphezulu obugxile kuphando oluzimeleyo, uphuhliso, imveliso, kunye norhwebo lweemveliso ezisekwe kwipeptide. Sikwabonelela ngeenkonzo ezibanzi zeCDMO, sibonelela ngezisombululo zepeptide ezilungiselelweyo kuxubo lwamayeza lwehlabathi, ezozithambiso, kunye nabathengi bezilwanyana.
Ipotfoliyo yethu yemveliso ibandakanya uninzi lwee-APIs ze-peptide, ezineemveliso eziphambili ezifana ne-Semaglutide kunye ne-Terlipressin emva kokugqiba ngempumelelo iifayile ze-US FDA DMF.
I-subsidiary yethu epheleleyo, i-Hubei JXBio Pharmaceutical Co., Ltd., isebenzisa imizila yemveliso ye-peptide ye-API eyakhelwe ukukhawulelana nemigangatho ye-cGMP esekwe yi-US FDA, kunye ne-NMPA yase-China. Eli ziko ligcina imizila yemveliso eyi-10 emikhulu kunye neyilinge, exhaswa yinkqubo engqongqo yolawulo lomgangatho wamachiza (QMS) kunye nenkqubo-sikhokelo eyomeleleyo yempilo nokukhuseleka kokusingqongileyo (EHS).
I-JXBio iphumelele ukuhlolwa kokuthotyelwa kwe-GMP yi-FDA yase-US kunye ne-NMPA yase-China, kwaye iye yamkelwa ziinkampani ezihamba phambili zamayeza zehlabathi ngokugqwesa kwayo kulawulo lwe-EHS - ubungqina bokuzibophelela kwethu kumgangatho, ukhuseleko, kunye nolawulo lokusingqongileyo.
IiNdawo zoShishino ezingundoqo
• Ubhaliso lwehlabathi kunye nokuthotyelwa kwe-peptide APIs
• Iipeptide zonyango lwezilwanyana kunye nezokuthambisa
• Iinkonzo zepeptide ezilungiselelweyo (CRO, CMO, OEM)
• Ii-Peptide-drug conjugates (PDCs), kuquka:
• I-Peptide-radionuclide
• Peptide-imolekyuli encinci
• IPeptide-protein
• Unyango lwe-Peptide-RNA
IIMVELISO EZIPHAMBILI
Ukuze ufumane iinkcukacha ezithe vetshe kwiimveliso zethu, nceda uqhagamshelane nathi.
I-Global API kunye nemibuzo ye-Cosmetic: Inombolo yomnxeba: + 86-15013529272;
Ubhaliso lwe-API kunye neeNkonzo ze-CDMO (imarike yase-USA EU): +86-15818682250
E-mail: jymed@jymedtech.com
Idilesi: Umgangatho 8 & 9, isakhiwo 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen
Ixesha lokuposa: Apr-24-2025





